The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment
Open accessAbstract
Diabetic peripheral neuropathy (DPN) refers to the development of peripheral nerve dysfunction in patients with diabetes when other causes are excluded. Diabetic distal symmetric polyneuropathy (DSPN) is the most representative form of DPN. As one of the most common complications of diabetes, its prevalence increases with the duration of diabetes. 10-15% of newly diagnosed T2DM patients have DSPN, and the prevalence can exceed 50% in patients with diabetes for more than 10 years. Bilateral limb pain, numbness, and paresthesia are the most common clinical manifestations in patients with DPN, and in severe cases, foot ulcers can occur, even leading to amputation. The etiology and pathogenesis of diabetic neuropathy are not yet completely clarified, but hyperglycemia, disorders of lipid metabolism, and abnormalities in insulin signaling pathways are currently considered to be the initiating factors for a range of pathophysiological changes in DPN. In the presence of abnormal metabolic factors, the normal structure and function of the entire peripheral nervous system are disrupted, including myelinated and unmyelinated nerve axons, perikaryon, neurovascular, and glial cells. In addition, abnormalities in the insulin signaling pathway will inhibit neural axon repair and promote apoptosis of damaged cells. Here, we will discuss recent advances in the study of DPN mechanisms, including oxidative stress pathways, mechanisms of microvascular damage, mechanisms of damage to insulin receptor signaling pathways, and other potential mechanisms associated with neuroinflammation, mitochondrial dysfunction, and cellular oxidative damage. Identifying the contributions from each pathway to neuropathy and the associations between them may help us to further explore more targeted screening and treatment interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Self-citationFeldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697
Li, Y., Teng, D., Shi, X., Qin, G., Qin, Y., Quan, H., Shi, B., Sun, H., Ba, J., Chen, B., et al. (2020) · BMJ · doi:10.1136/bmj.m997 · Cited by 1,580
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Insulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293
Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells
de Murcia, J. M., Niedergang, C., Trucco, C., Ricoul, M., Dutrillaux, B., Mark, M., Oliver, F. J., Masson, M., Dierich, A., LeMeur, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7303 · Cited by 1,056
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915
The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
Gordois, A., Scuffham, P., Shearer, A., Oglesby, A., & Tobian, J. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1790 · Cited by 734
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
Cameron, N. E., Eaton, S. E. M., Cotter, M. A., & Tesfaye, S. (2001) · Diabetologia · doi:10.1007/s001250100001 · Cited by 701
Double‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy
Harati, Y., Gooch, C., Swenson, M., Edelman, S., Greene, D., Raskin, P., Donofrio, P., Cornblath, D., Sachdeo, R., Siu, C. O., et al. (1998) · Neurology · doi:10.1212/wnl.50.6.1842 · Cited by 546
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Papachristoforou, E., Lambadiari, V., Maratou, E., & Makrilakis, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7489795 · Cited by 479
Current challenges and opportunities in the prevention and management of diabetic foot ulcers.
Jeffcoate, W. J., Vileikyte, L., Boyko, E. J., Armstrong, D. G., & Boulton, A. J. M. (2018) · Diabetes Care · doi:10.2337/dc17-1836 · Cited by 475
Krebs cycle Reborn in macrophage immunometabolism
Ryan, D. G., & O'Neill, L. A. J. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-081619-104850 · Cited by 444
TUCK, R. R., SCHMELZER, J. D., & LOW, P. A. (1984) · Brain · doi:10.1093/brain/107.3.935 · Cited by 418
Elafros, M. A., Andersen, H., Bennett, D. L., Savelieff, M. G., Viswanathan, V., Callaghan, B. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00188-0 · Cited by 387
Salzer, J. L. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020529 · Cited by 364
Schwann cell interactions with axons and microvessels in diabetic neuropathy
Gonçalves, N. P., Vægter, C. B., Andersen, H., Østergaard, L., Calcutt, N. A., & Jensen, T. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.201 · Cited by 305
Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
Dewanjee, S., Das, S., Das, A. K., Bhattacharjee, N., Dihingia, A., Dua, T. K., Kalita, J., & Manna, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.034 · Cited by 300
Cross-Talk between AMPK and mTOR in Regulating Energy Balance
Xu, J., Ji, J., & Yan, X.-H. (2012) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.500245 · Cited by 299
The epidemiology and risk factors of chronic polyneuropathy
Hanewinckel, R., van Oijen, M., Ikram, M. A., & van Doorn, P. A. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-015-0094-6 · Cited by 293
Petersen, E. A., Stauss, T. G., Scowcroft, J. A., Brooks, E. S., White, J. L., Sills, S. M., Amirdelfan, K., Guirguis, M. N., Xu, J., Yu, C., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0538 · Cited by 277
Myelin plasticity and nervous system function
Monje, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061853 · Cited by 274
Diagnosis and Management of Diabetic Foot Complications
Boulton, A., Armstrong, D., Krisner, R., Attinger, C., Lavery, L., Lipsky, B., Mills, J., & Steinberg, J. (2018) · ADA Clinical Compendia · doi:10.2337/db20182-1 · Cited by 269
Peripheral nerve injury and myelination: Potential therapeutic strategies
Modrak, M., Talukder, M. A. H., Gurgenashvili, K., Noble, M., & Elfar, J. C. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24538 · Cited by 266
Opposing Extracellular Signal-Regulated Kinase and Akt Pathways Control Schwann Cell Myelination
Ogata, T., Iijima, S., Hoshikawa, S., Miura, T., Yamamoto, S.-I., Oda, H., Nakamura, K., & Tanaka, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5520-03.2004 · Cited by 264
Schwann cell functions in peripheral nerve development and repair
Bosch-Queralt, M., Fledrich, R., & Stassart, R. M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105952 · Cited by 240
Role of Poly(ADP-Ribose) Polymerase Activation in Diabetic Neuropathy
Obrosova, I. G., Li, F., Abatan, O. I., Forsell, M. A., Komjáti, K., Pacher, P., Szabó, C., & Stevens, M. J. (2004) · Diabetes · doi:10.2337/diabetes.53.3.711 · Cited by 236
Epidemiology of polyneuropathy in diabetes and prediabetes
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53480-4.00001-1 · Cited by 235
Soltoff, S. P., Rabin, S. L., Cantley, L. C., & Kaplan, D. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41950-3 · Cited by 231
Obrosova, I. G., Drel, V. R., Pacher, P., Ilnytska, O., Wang, Z. Q., Stevens, M. J., & Yorek, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3435 · Cited by 231
Li, R., Li, Y., Wu, Y., Zhao, Y., Chen, H., Yuan, Y., Xu, K., Zhang, H., Lu, Y., Wang, J., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.044 · Cited by 231
Direct Insulin Signaling of Neurons Reverses Diabetic Neuropathy
Brussee, V., Cunningham, F. A., & Zochodne, D. W. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1824 · Cited by 226
Callaghan, B. C., Xia, R., Banerjee, M., de Rekeneire, N., Harris, T. B., Newman, A. B., Satterfield, S., Schwartz, A. V., Vinik, A. I., Feldman, E. L., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0081 · Cited by 220
Chen, Y.-Q., Su, M., Walia, R. R., Hao, Q., Covington, J. W., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8225 · Cited by 217
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population
Callaghan, B. C., Xia, R., Reynolds, E., Banerjee, M., Rothberg, A. E., Burant, C. F., Villegas-Umana, E., Pop-Busui, R., & Feldman, E. L. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3745 · Cited by 212
Structure and function of poly(ADP-ribose) polymerase
de Murcia, G., Schreiber, V., Molinete, M., Saulier, B., Poch, O., Masson, M., Niedergang, C., & de Murcia, J. M. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00928438 · Cited by 206
Diabetes and obesity are the main metabolic drivers of peripheral neuropathy
Callaghan, B. C., Gao, L., Li, Y., Zhou, X., Reynolds, E., Banerjee, M., Pop‐Busui, R., Feldman, E. L., & Ji, L. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.531 · Cited by 201
The dynamic plasticity of insulin production in β-cells
Boland, B. B., Rhodes, C. J., & Grimsby, J. S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.04.010 · Cited by 194
Miller, J. W. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy023 · Cited by 194
A new look at painful diabetic neuropathy
Sloan, G., Shillo, P., Selvarajah, D., Wu, J., Wilkinson, I. D., Tracey, I., Anand, P., & Tesfaye, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.08.020 · Cited by 189
Cellular Responses to DNA Damage in the Absence of Poly(ADP-ribose) Polymerase
Rhun, Y. L., Kirkland, J. B., & Shah, G. M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8257 · Cited by 187
The Potential Role of Thiamine (Vitamin B1) in Diabetic Complications
Thornalley, P. (2005) · Current Diabetes Reviews · doi:10.2174/157339905774574383 · Cited by 183
Pacher, P., & Szabó, C. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1568 · Cited by 180
Ma, X., Ma, J., Leng, T., Yuan, Z., Hu, T., Liu, Q., & Shen, T. (2023) · Renal Failure · doi:10.1080/0886022x.2022.2146512 · Cited by 176
Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders
Marini, F., Giusti, F., Palmini, G., & Brandi, M. L. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06523-7 · Cited by 174
Current concepts in the management of diabetic polyneuropathy
Ziegler, D., Παπάνας, Ν., Schnell, O., Nguyen, B. D., Nguyen, K. T., Kulkantrakorn, K., & Deerochanawong, C. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13401 · Cited by 171
The impact of diabetes on corneal nerve morphology and ocular surface integrity
Markoulli, M. P., Flanagan, J., Tummanapalli, S. S., Wu, J., & Willcox, M. D. P. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.10.006 · Cited by 168
Mechanism of Peripheral Nerve Stimulation in Chronic Pain
Lin, T. G., Gargya, A., Singh, H., Sivanesan, E., & Gulati, A. (2020) · Pain Medicine · doi:10.1093/pm/pnaa164 · Cited by 167
Giannini, C., & Dyck, P. J. (1995) · Annals of Neurology · doi:10.1002/ana.410370412 · Cited by 165
Insulin action in the brain regulates both central and peripheral functions
Agrawal, R., Reno, C. M., Sharma, S., CHRISTENSEN, C. G., Huang, Y., & Fisher, S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00642.2020 · Cited by 162
Metabolic syndrome and peripheral neuropathy
Kazamel, M., Stino, A. M., & Smith, A. G. (2021) · Muscle & Nerve · doi:10.1002/mus.27086 · Cited by 161
Huang, J. T.-J., Verkhratsky, A., & Fernyhough, P. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.08.009 · Cited by 148
Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy
Liu, Y.-P., Shao, S.-J., & Guo, H.-D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117459 · Cited by 144
Self-citationPoly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory Neuropathy
Ilnytska, O., Lyzogubov, V. V., Stevens, M. J., Drel, V. R., Mashtalir, N., Pacher, P., Yorek, M. A., & Obrosova, I. G. (2006) · Diabetes · doi:10.2337/db06-0067 · Cited by 141
Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials
Kawano, T., Inokuchi, J., Eto, M., Murata, M., & Kang, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111748 · Cited by 130
Obrosova, I. G., Xu, W., Lyzogubov, V. V., Ilnytska, O., Mashtalir, N., Vareniuk, І., Pavlov, I. A., Zhang, J., Slusher, B. S., & Drel, V. R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.09.013 · Cited by 119
A Role for Insulin in Diabetic Neuropathy
Grote, C. W., & Wright, D. E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00581 · Cited by 115
Management of diabetic neuropathy
Cernea, S., & Raz, I. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154867 · Cited by 115
p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?
Bengal, E., Aviram, S., & Hayek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186480 · Cited by 114
Role of advanced glycation end products and insulin resistance in diabetic nephropathy
Parwani, K., & Mandal, P. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1797106 · Cited by 113
Vinik, A. I., Perrot, S., Vinik, E. J., Pazdera, L., Jacobs, H., Stoker, M., Long, S., Snijder, R. J., van der Stoep, M., Ortega, E., et al. (2016) · BMC Neurology · doi:10.1186/s12883-016-0752-7 · Cited by 109
Regulatory Mechanisms of the Wnt/β-Catenin Pathway in Diabetic Cutaneous Ulcers
Zhang, H., Nie, X., Shi, X., Zhao, J., Chen, Y., Yao, Q.-Y., Sun, C., & Yang, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01114 · Cited by 108
Diabetic Neuropathy Differs in Type 1 and Type 2 Diabetes
Sima, A. A. F., & Kamiya, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.004 · Cited by 105
Bell, D. S. H. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14734 · Cited by 105
The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy
Østergaard, L., Finnerup, N. B., Terkelsen, A. J., Olesen, R. A., Drasbek, K. R., Knudsen, L., Jespersen, S. N., Frystyk, J., Charles, M., Thomsen, R. W., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3461-z · Cited by 104
Vargas-Soria, M., García-Alloza, M., & Corraliza-Gómez, M. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02740-x · Cited by 104
Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental Diabetic Neuropathy
Freeman, O. J., Unwin, R. D., Dowsey, A. W., Begley, P., Ali, S., Hollywood, K. A., Rustogi, N., Petersen, R. S., Dunn, W. B., Cooper, G. J. S., et al. (2015) · Diabetes · doi:10.2337/db15-0835 · Cited by 102
Gab1 Mediates Neurite Outgrowth, DNA Synthesis, and Survival in PC12 Cells
Korhonen, J. M., Said, F. A., Wong, A. J., & Kaplan, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37307 · Cited by 102
Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems
Niimi, N., Yako, H., Takaku, S., Chung, S. K., & Sango, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031031 · Cited by 102
Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
Oshitari, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032927 · Cited by 102
Collateral Glucose-Utlizing Pathwaya in Diabetic Polyneuropathy
Mizukami, H., & Osonoi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010094 · Cited by 101
Hanewinckel, R., Drenthen, J., Ligthart, S., Dehghan, A., Franco, O. H., Hofman, A., Ikram, M. A., & van Doorn, P. A. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314171 · Cited by 98
Beirowski, B., Wong, K. M., Babetto, E., & Milbrandt, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620761114 · Cited by 94
Local insulin and the rapid regrowth of diabetic epidermal axons
Guo, G., Kan, M., Martínez, J. A., & Zochodne, D. W. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.012 · Cited by 88
DiAntonio, A. (2019) · Pain · doi:10.1097/j.pain.0000000000001528 · Cited by 88
Drel, V. R., Lupachyk, S., Shevalye, H., Vareniuk, І., Xu, W., Zhang, J., Delamere, N. A., Shahidullah, M., Slusher, B. S., & Obrosova, I. G. (2010) · Endocrinology · doi:10.1210/en.2009-1342 · Cited by 86
Du, W., Wang, N., Li, F., Jia, K., An, J., Liu, Y., Wang, Y., Zhu, L., Song, Z., & Hao, J. (2019) · The FASEB Journal · doi:10.1096/fj.201900127r · Cited by 86
Self-citationPeripheral nervous system insulin resistance in ob/ob mice
Grote, C. W., Groover, A. L., Ryals, J. M., Geiger, P. C., Feldman, E. L., & Wright, D. E. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-15 · Cited by 84
ERK/MAPK Signaling Is Required for Pathway-Specific Striatal Motor Functions
Hutton, S. R., Otis, J. M., Kim, E. M., Lamsal, Y., Stuber, G. D., & Snider, W. D. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0473-17.2017 · Cited by 84
Diagnosis and management of sensory polyneuropathy
Gwathmey, K. G., & Pearson, K. (2019) · BMJ · doi:10.1136/bmj.l1108 · Cited by 83
Lupachyk, S., Shevalye, H., Maksimchyk, Y., Drel, V. R., & Obrosova, I. G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.037 · Cited by 82
Weisman, A., Bril, V., Ngo, M., Lovblom, L. E., Halpern, E. M., Orszag, A., & Perkins, B. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058783 · Cited by 81
Weigert, C., Brodbeck, K., Sawadogo, M., Häring, H. U., & Schleicher, E. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313524200 · Cited by 80
Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR
Maiese, K. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.179032 · Cited by 79
Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes
Kamiya, H., Murakawa, Y., Zhang, W., & Sima, A. A. F. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.541 · Cited by 77
Wang, X., Li, Q., Han, X., Gong, M., Yu, Z. H., & Xu, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.655591 · Cited by 77
Carstens, M. H., Quintana, F. J., Calderwood, S. T., Sevilla, J. P., Ríos, A. B., Rivera, C. M., Calero, D. W., Zelaya, M. L., Garcia, N., Bertram, K. A., et al. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0497 · Cited by 76
Sawangjit, R., Thongphui, S., Chaichompu, W., & Phumart, P. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2020.0068 · Cited by 75
Rehm, S., Binder, A., & Baron, R. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.483675 · Cited by 72
Grote, C. W., Morris, J. K., Ryals, J. M., Geiger, P. C., & Wright, D. E. (2011) · Experimental Diabetes Research · doi:10.1155/2011/212571 · Cited by 72
Liu, S.-Y., Chen, L., Li, X., Hu, Q., & He, L. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.12.011 · Cited by 71
Skin AGEs and diabetic neuropathy
Papachristou, S., Pafili, K., & Παπάνας, Ν. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00697-7 · Cited by 71
Zhang, W., Murakawa, Y., Woźniak, K., Slusher, B. S., & Sima, A. A. F. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.052 · Cited by 69
WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer
Du, W., Menjivar, R. E., Donahue, K. L., Kadiyala, P., Velez-Delgado, A., Brown, K. L., Watkoske, H. R., He, X., Carpenter, E. S., Angeles, C. V., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220503 · Cited by 68
Microvascular Dysfunction in the Context of Diabetic Neuropathy
Stirban, A. O. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0541-x · Cited by 67
Zhu, L., Hao, J., Cheng, M., Zhang, C., Huo, C., Liu, Y., Du, W., & Zhang, X. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.034 · Cited by 67
Self-citationTowns, R., Kabeya, Y., Yoshimori, T., Guo, C., Shangguan, Y., Hong, S., Kaplan, M. J., Klionsky, D. J., & Wiley, J. W. (2005) · Autophagy · doi:10.4161/auto.1.3.2068 · Cited by 66
Non-pharmacologic treatments for symptoms of diabetic peripheral neuropathy: a systematic review
Nesbit, S. A., Sharma, R., Waldfogel, J. M., Zhang, A. W., Bennett, W. L., Yeh, H., Chelladurai, Y., Feldman, D. R., Robinson, K. A., & Dy, S. M. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1497958 · Cited by 66
Xu, Q., Pan, J., Yu, J., Liu, X., Liu, L., Zuo, X., Wu, P., Deng, H., Zhang, J., & Ji, A. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.033 · Cited by 65
Recent advances in understanding the role of oxidative stress in diabetic neuropathy
Shakeel, M. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.029 · Cited by 64
Pan, Q., Li, Q., Deng, W., Zhao, D., Qi, L., Huang, W., Ma, L., Li, H., Li, Y., Lyu, X., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00617 · Cited by 61
Yin, Y., Qu, H., Yang, Q., Fang, Z., & Gao, R. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153749 · Cited by 61
Mechanism of Schwann cells in diabetic peripheral neuropathy: A review
Li, J., Guan, R., & Pan, L. (2023) · Medicine · doi:10.1097/md.0000000000032653 · Cited by 61
Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy
Hackett, A. R., Strickland, A. M., & Milbrandt, J. (2019) · Glia · doi:10.1002/glia.23755 · Cited by 60
Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review
Shabeeb, D., Najafi, M., Hasanzadeh, G., Hadian, M. R., Musa, A., & Shirazi, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.026 · Cited by 54
Alvarado, A. M., & Navarro, S. A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4078695 · Cited by 52
Blood–Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model
Takeshita, Y., Sato, R., & Kanda, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010062 · Cited by 52
Zhao, W., Zeng, H., Zhang, X., Liu, F., Pan, J., Zhao, J., Zhao, J., Li, L., Bao, Y., Liu, F., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.01.018 · Cited by 49
Hur, J., O’Brien, P. D., Nair, V., Hinder, L. M., McGregor, B. A., Jagadish, H. V., Kretzler, M., Brosius, F. C., & Feldman, E. L. (2016) · Diabetologia · doi:10.1007/s00125-016-3913-8 · Cited by 47
C‐peptide antioxidant adaptive pathways in β cells and diabetes
Luppi, P., & Drain, P. F. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12522 · Cited by 47
Yao, K., Tan, J., Gu, W., Ye, P., & Wang, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.198 · Cited by 45
The challenges of diabetic polyneuropathy: a brief update
Zochodne, D. W. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000723 · Cited by 45
Biomarkers in diabetic neuropathy
Adki, K. M., & Kulkarni, Y. A. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1837183 · Cited by 45
Obrosova, I. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.709 · Cited by 44
Irving, G. A., Tanenberg, R. J., Raskin, J., Risser, R. C., & Malcolm, S. K. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12452 · Cited by 43
Wang, Y., Schmeichel, A. M., Iida, H., Schmelzer, J. D., & Low, P. A. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1513 · Cited by 41
Amyloid Proteins and Peripheral Neuropathy
Albariqi, M. M. H., Engelsman, S., Eijkelkamp, N., & Höppener, J. W. M. (2020) · Cells · doi:10.3390/cells9061553 · Cited by 41
Wnt Pathway in Pancreatic Development and Pathophysiology
Napolitano, T., Silvano, S., Ayachi, C., Plaisant, M., de Veiga, A. S., Fofo, H., Charles, B., & Collombat, P. (2023) · Cells · doi:10.3390/cells12040565 · Cited by 41
Beirowski, B. (2018) · BioEssays · doi:10.1002/bies.201800075 · Cited by 38
Williams Textbook of Endocrinology - 14th Revised Edition
Badiu, C. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.416 · Cited by 38
Fan, J., Pan, Q., Gao, Q., Li, W., Xiao, F., & Guo, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/2482453 · Cited by 37
Pan, Q., Li, Q., Deng, W., Zhao, D., Qi, L., Huang, W., Ma, L., Li, H., Li, Y., Lyu, X., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01144 · Cited by 33
Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats
Aghanoori, M., Smith, D. R., Chowdhury, S. R., Sabbir, M. G., Calcutt, N. A., & Fernyhough, P. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.005 · Cited by 32
Hu, Y., Hu, Z., Tang, W., Liu, W., Wu, X., & Pan, C. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s354872 · Cited by 32
Self-citationMahmoudinezhad, M., Vajdi, M., & Farhangi, M. A. (2020) · Nutrition · doi:10.1016/j.nut.2020.111041 · Cited by 31
Shettar, A., & Muttagi, G. (2012) · Peptides · doi:10.1016/j.peptides.2012.04.012 · Cited by 30
Langer, H. T., Afzal, S., Kempa, S., & Spuler, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-58213-1 · Cited by 29
Sirisha, A., Gaur, G. S., Pal, P., Bobby, Z., Balakumar, B., & Pal, G. K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245395 · Cited by 29
Vieira, W. F., Malange, K. F., de Magalhães, S. F., Lemes, J. B. P., dos Santos, G. G., Nishijima, C. M., de Oliveira, A. L. R., da Cruz‐Höfling, M. A., Tambeli, C. H., & Parada, C. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-19947-2 · Cited by 28
Ehrlich, W., Huser, H., & Kr�ger, H. (1995) · Rheumatology International · doi:10.1007/bf00301776 · Cited by 27
Wang, D., Wang, C., Duan, X., Yang, Z., Bai, Z., Hu, H., Yan, L., & Shen, J. (2017) · European Radiology · doi:10.1007/s00330-017-5043-1 · Cited by 27
Peripheral Nerve Development and the Pathogenesis of Peripheral Neuropathy: the Sorting Point
Previtali, S. C. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01080-z · Cited by 27
Thyroid status in patients with Type 2 diabetes attending a Tertiary Care Hospital in Eastern India
Ghosh, S., Pramanik, S., Mukhopadhyay, P., Bhattacharjee, R., Mukherjee, B., Mondal, S., Ghosh, I., Bari, R., & Chowdhury, S. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_572_17 · Cited by 26
Daniels, L. J., Annandale, M., Koutsifeli, P., Li, X., Bussey, C. T., van Hout, I., Bunton, R. W., Davis, P. J., Coffey, S., Katare, R., et al. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00150-7 · Cited by 26
Diabetic Neuropathy: Review on Molecular Mechanisms
Sanaye, M., & Kavishwar, S. A. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666210816093111 · Cited by 25
Prevalence and Clinical Significance of Subclinical Hypothyroidism in Diabetic Peripheral Neuropathy
Allam, M. A., Nassar, Y., Shabana, H., Mostafa, S., Khalil, F., Zedan, H. A.-M., Abo-Ghabsha, M. E.-S., Abdelghaffar, A., Essmat, A., & Elmahdi, E. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s337779 · Cited by 25
Emerging Nonpharmacologic Interventions to Treat Diabetic Peripheral Neuropathy
Enders, J. D., Elliott, D., & Wright, D. E. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0158 · Cited by 25
Shetter, A. R., Muttagi, G., & Sagar, C. (2010) · Cell Biology International · doi:10.1042/cbi20100523 · Cited by 23
Nikitin, A. G., Chudakova, D. A., Strokov, I. A., Bursa, T. R., Chistiakov, D. A., & Nosikov, V. V. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.020 · Cited by 23
Zhang, C.-H., Lv, X., Du, W., Cheng, M., Liu, Y.-P., Zhu, L., & Hao, J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111502 · Cited by 23
Self-citationDiabetic polyneuropathy: Bridging the translational gap
Kobayashi, M., & Zochodne, D. W. (2020) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12392 · Cited by 23
Jiang, D.-Q., Li, M., Yanjiao, M., Wang, Y., & Wang, Y. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.07.028 · Cited by 22
Sciatic nerve microvascular permeability in type 2 diabetes decreased in patients with neuropathy
Jende, J. M. E., Mooshage, C. M., Κender, Ζ., Schimpfle, L., Juerchott, A., Heiland, S., Nawroth, P. P., Bendszus, M., Kopf, S., & Kurz, F. T. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51563 · Cited by 22
Yu, J., Zhao, Y., Xu, L., Li, W., Zhang, H., Ping, F., & Li, Y. (2023) · Mediators of Inflammation · doi:10.1155/2023/8974960 · Cited by 22
Impaired Nociception in the Diabetic Ins2+/Akita Mouse
Vastani, N., Guenther, F., Gentry, C., Austin, A. L. F., King, A., Bevan, S., & Andersson, D. A. (2018) · Diabetes · doi:10.2337/db17-1306 · Cited by 20
Zhang, Y., Fan, D., Zhang, Y., Zhang, S., Wang, H., Liu, Z., & Wang, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-94284-4 · Cited by 20
Microvascular tissue plasminogen activator is reduced in diabetic neuropathy
Hafer‐Macko, C. E., Ivey, F. M., Sorkin, J. D., & Macko, R. F. (2007) · Neurology · doi:10.1212/01.wnl.0000266391.20707.83 · Cited by 19
Tatsumi, Y., Kato, A., Niimi, N., Yako, H., Himeno, T., Kondo, M., Tsunekawa, S., Kato, Y., Kamiya, H., Nakamura, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084405 · Cited by 18
Rachana, K. S., Manu, M. S., & Advirao, G. M. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.017 · Cited by 17
Differential gene expression profiling of the sciatic nerve in type 1 and type 2 diabetic mice
Gu, Y. F., Qiu, Z.-L., Liu, D.-Z., Sun, G., Guan, Y., Hei, Z., & Li, X. (2018) · Biomedical Reports · doi:10.3892/br.2018.1135 · Cited by 17
Huang, S.-K., Lü, C.-W., Lin, T., & Wang, S. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210902165739 · Cited by 16
DNMT1, a Novel Regulator Mediating mTORC1/mTORC2 Pathway-Induced NGF Expression in Schwann Cells
Cheng, M., Lv, X., Zhang, C., Du, W., Liu, Y., Zhu, L., & Hao, J. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2637-1 · Cited by 15
Self-citationPan, S., Hada, S. S., Liu, Y., Hu, C., Zhou, M., Zheng, S., Xu, M., Shi, C., Yin, S., & Xie, X. (2022) · Stem Cells International · doi:10.1155/2022/6897056 · Cited by 15
Self-citationSuo, J., Wang, M., Zhang, P., Lu, Y., Xu, R., Zhang, L., Qiu, S., Zhang, Q., Qian, Y., Meng, J., et al. (2020) · Regenerative Medicine Research · doi:10.1051/rmr/200001 · Cited by 14
Self-citationJiang, D.-Q., Zhao, S.-H., Li, M., Jiang, L.-L., Wang, Y., & Wang, Y. (2018) · Medicine · doi:10.1097/md.0000000000013020 · Cited by 13
Insulin-Ameliorated Peripheral Motor Neuropathy in Spontaneously Diabetic WBN/Kob Rats
Ozaki, K., Yamano, S., Matsuura, T., & Narama, I. (2013) · Journal of Veterinary Medical Science · doi:10.1292/jvms.13-0184 · Cited by 11
Elmazoğlu, Z., Prnová, M. Š., Štefek, M., Ceylan, A. F., Aschner, M., Rangel‐López, E., Santamaría, A., & Karasu, Ç. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00349-7 · Cited by 11
Targeted disruption of PKC from AKAP signaling complexes
Limaye, A. J., Bendzunas, G. N., & Kennedy, E. J. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00106j · Cited by 11
Jasim, H. S., Shafeeq, N. K., & Abass, E. A. (2022) · PubMed · doi:10.22092/ari.2022.357389.2029 · Cited by 11
Reynès, C., Beaume, J. B., Latil-Plat, F., Ennaifer, H., Rocher, L., Antoine‐Jonville, S., Benamo, E., Knapp, Y., & Vinet, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab414 · Cited by 10
Chau, D. D., Li, W., Chan, W. W. R., Sun, J. K., Zhai, Y., Chow, H., & Lau, K. (2022) · The FASEB Journal · doi:10.1096/fj.202200757r · Cited by 9
Zaman, A., Arif, Z., Moinuddin, M., Akhtar, K., Ali, W. M., & Alam, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216736 · Cited by 6
Beneficial effect of thyrotropin-releasing hormone on neuropathy in diabetic rats
Gül, H., Odabaşı, Z., Yıldız, O., Özata, M., Deniz, G., Vural, O., & Işimer, A. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00028-5 · Cited by 3
Visualizing WNT signaling in mammalian systems
van der Wal, T., & van Amerongen, R. (2023) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2023.02.001 · Cited by 2
Metadata
- Authors
- Zhu, J., Hu, Z., Luo, Y., Liu, Y., Luo, W., Du, X., Luo, Z., Hu, J., & Peng, S.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2024-01-09
- Volume
- 14
- Pages
- 1265372-1265372
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W4391100756
- Cited by
- 310
- References
- 169
- FWCI
- 73.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.